Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Treatment of a Buschke-Löwenstein Tumor With Radiotherapy and Cemiplimab.
JAMA Dermatol
January 2025
Department of Medical Oncology, Houston Methodist Hospital, Houston, Texas.
Buschke-Lowenstein tumour.
BMJ Case Rep
January 2025
Department of Dermatology, Venereology and Leprosy, BLDE Deemed to be University, Vijayapura, Karnataka, India
Buschke-Löwenstein Tumor (BLT): Successful Treatment of Human Papillomavirus (HPV)-Associated Squamous Cell Carcinoma With Radical Surgery and Chemotherapy.
Cureus
November 2024
Emergency Medicine, Public Health Institution Dom Zdravlja Prijedo, Prijedor, BIH.
The giant condyloma acuminatum, known as the Buschke-Löwenstein tumor (BLT), is an uncommon, slow-growing, cauliflower-like tumor located in the anogenital region. It has a high recurrence rate, is sexually transmitted, and is often linked with immunosuppression. This tumor is commonly associated with human papillomavirus (HPV) infection, making HPV one of the most prevalent sexually transmitted infections affecting the perineal and genital regions.
View Article and Find Full Text PDFCase report: A case of giant breast skin warts caused by HPV infection.
Front Oncol
August 2024
Department of Thyroid and Breast Surgery, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
GCA, also known as Buschke-Lowenstein tumor, is a rare sexually transmitted disease associated with HPV types 6 and 111. These warts are considered histologically benign, but there is a risk of localized invasion and development of malignancy. This malignant transformation occurs most often in the perianal and vulvar areas, and involvement of other sites is relatively rare2.
View Article and Find Full Text PDFBuschke-Lowenstein Tumor.
Urology
November 2024
Department of Surgery, Division of Urology, Federal University of São Paulo, São Paulo, São Paulo, Brazil.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!